Shield Therapeutics inks licencing agreement for iron deficiency drug
(Alliance News) - Shield Therapeutics PLC on Tuesday reported an exclusive deal with a Japanese distributor, as it looks keep expanding Accrufer's global footprint. Read More
Price | 2.85p on 09-07-2025 | at 06:50:00
---|---|
Change | 0.00p 0% |
Buy | 3.00p |
Sell | 2.70p |
Buy / Sell STX Shares |
Last Trade: | Unknown 490.00 at 2.85p |
Day's Volume: | 0 |
Last Close: | 2.85p |
Open: | 0.00p |
ISIN: | GB00BYV81293 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 1.525p - 5.80p |
Market Capitalisation: | £30m |
VWAP: | 0.00p |
Shares in Issue: | 1,042m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 490 | 2.85p | Ordinary |
16:19:43 - 08-Jul-25 |
Buy* | 115,850 | 2.89p | Ordinary |
15:24:48 - 08-Jul-25 |
Sell* | 7,059 | 2.833p | Ordinary |
15:24:24 - 08-Jul-25 |
Buy* | 250,000 | 2.90p | Ordinary |
15:20:39 - 08-Jul-25 |
Buy* | 250,000 | 2.895p | Ordinary |
15:15:52 - 08-Jul-25 |
Buy* | 28 | 3.00p | SI Trade |
15:11:53 - 08-Jul-25 |
Buy* | 35 | 3.00p | SI Trade |
15:11:53 - 08-Jul-25 |
Sell* | 976 | 2.70p | SI Trade |
15:11:53 - 08-Jul-25 |
Sell* | 203 | 2.70p | SI Trade |
15:11:53 - 08-Jul-25 |
Buy* | 4,864 | 3.00p | SI Trade |
15:11:53 - 08-Jul-25 |
Shield Thera (STX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
22nd May 2025 5:06 pm | RNS | Result of AGM |
24th Apr 2025 7:06 am | RNS | Audited results for the year ended 31 Dec 2024 |
22nd Apr 2025 7:01 am | RNS | Licence Agreement in Japan for ACCRUFeR® |
17th Apr 2025 11:23 am | RNS | Q1 2025 Trading Update |
11th Mar 2025 7:00 am | RNS | ACCRUFeR® launched in Canada |
13th Feb 2025 4:15 pm | RNS | PDMR Transaction Notification |
13th Feb 2025 7:00 am | RNS | Grant of Share Options |
5th Feb 2025 7:00 am | RNS | Unaudited full year trading update |
27th Jan 2025 7:00 am | RNS | Anders Lundstrom appointed CEO |
24th Dec 2024 11:25 am | RNS | Result of General Meeting & Total Voting Rights |